You are here

Meeting Highlights

American Society of Clinical Oncology 2007

Walter Alexander
PDF version: 
The author discusses advances in treatment, including cetuximab (Erbitux) for colorectal cancer, dasatinib (Sprycel) for chronic myeloid leukemia, enzastaurin as well as platinum combinations with pemetrexed (Alimta) and gemcitabine (Gemzar) for non–small-cell lung cancer, denileukin diftitox (Ontak) for T-cell lymphoma, and capecitabine (Xeloda) with bevacizumab (Avastin) for metastatic breast cancer.